184 related articles for article (PubMed ID: 11151749)
21. Distribution of clozapine and desmethylclozapine between blood and brain in rats.
Weigmann H; Härtter S; Fischer V; Dahmen N; Hiemke C
Eur Neuropsychopharmacol; 1999 Mar; 9(3):253-6. PubMed ID: 10208296
[TBL] [Abstract][Full Text] [Related]
22. N-desmethylclozapine, an insensitive marker of clozapine-induced agranulocytosis and granulocytopenia.
Combs MD; Perry PJ; Bever KA
Pharmacotherapy; 1997; 17(6):1300-4. PubMed ID: 9399615
[TBL] [Abstract][Full Text] [Related]
23. The effect of variable cigarette consumption on the interaction with clozapine and olanzapine.
Haslemo T; Eikeseth PH; Tanum L; Molden E; Refsum H
Eur J Clin Pharmacol; 2006 Dec; 62(12):1049-53. PubMed ID: 17089108
[TBL] [Abstract][Full Text] [Related]
24. Longitudinal effects of clozapine concentration and clozapine to N-desmethylclozapine ratio on cognition: A mediation model.
Dal Santo F; Jarratt-Barnham I; González-Blanco L; García-Portilla MP; Bobes J; Fernández-Egea E
Eur Neuropsychopharmacol; 2020 Apr; 33():158-163. PubMed ID: 32057590
[TBL] [Abstract][Full Text] [Related]
25. Reduction of clozapine-induced hypersalivation by pirenzepine is safe.
Schneider B; Weigmann H; Hiemke C; Weber B; Fritze J
Pharmacopsychiatry; 2004 Mar; 37(2):43-5. PubMed ID: 15048609
[TBL] [Abstract][Full Text] [Related]
26. Pharmacoclinical strategy in neuroleptic resistant schizophrenic patients treated by clozapine: clinical evolution, concentration of plasma and red blood cell clozapine and desmethylclozapine, whole blood serotonin and tryptophan.
Aymard N; Viala A; Baldacci C; Smagghe PO; Vacheron MN; Caroli F
Prog Neuropsychopharmacol Biol Psychiatry; 1999 Jan; 23(1):25-41. PubMed ID: 10368854
[TBL] [Abstract][Full Text] [Related]
27. Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics.
Spina E; Avenoso A; Facciolà G; Scordo MG; Ancione M; Madia AG; Ventimiglia A; Perucca E
Psychopharmacology (Berl); 2000 Jan; 148(1):83-9. PubMed ID: 10663421
[TBL] [Abstract][Full Text] [Related]
28. Correlation of antipsychotic and prolactin concentrations in children and adolescents acutely treated with haloperidol, clozapine, or olanzapine.
Alfaro CL; Wudarsky M; Nicolson R; Gochman P; Sporn A; Lenane M; Rapoport JL
J Child Adolesc Psychopharmacol; 2002; 12(2):83-91. PubMed ID: 12188977
[TBL] [Abstract][Full Text] [Related]
29. Plasma clozapine concentration coefficients of variation in a long-term study.
Diaz FJ; de Leon J; Josiassen RC; Cooper TB; Simpson GM
Schizophr Res; 2005 Jan; 72(2-3):131-5. PubMed ID: 15560958
[TBL] [Abstract][Full Text] [Related]
30. Serum concentrations of clozapine and norclozapine in the prediction of relapse of patients with schizophrenia.
Xiang YQ; Zhang ZJ; Weng YZ; Zhai YM; Li WB; Cai ZJ; Tan QR; Wang CY
Schizophr Res; 2006 Apr; 83(2-3):201-10. PubMed ID: 16524698
[TBL] [Abstract][Full Text] [Related]
31. Clozapine and norclozapine concentrations in serum and plasma samples from schizophrenic patients.
Hermida J; Paz E; Tutor JC
Ther Drug Monit; 2008 Feb; 30(1):41-5. PubMed ID: 18223461
[TBL] [Abstract][Full Text] [Related]
32. Ciprofloxacin strongly inhibits clozapine metabolism: two case reports.
Brouwers EE; Söhne M; Kuipers S; van Gorp EC; Schellens JH; Koks CH; Beijnen JH; Huitema AD
Clin Drug Investig; 2009; 29(1):59-63. PubMed ID: 19067475
[TBL] [Abstract][Full Text] [Related]
33. Bioequivalence of clozapine orally disintegrating 100-mg tablets compared with clozapine solid oral 100-mg tablets after multiple doses in patients with schizophrenia.
Golden G; Honigfeld G
Clin Drug Investig; 2008; 28(4):231-9. PubMed ID: 18345713
[TBL] [Abstract][Full Text] [Related]
34. Clozapine: more than 900 mg/day may be needed.
Maccall C; Billcliff N; Igbrude W; Natynczuk S; Spencer EP; Flanagan RJ
J Psychopharmacol; 2009 Mar; 23(2):206-10. PubMed ID: 18515467
[TBL] [Abstract][Full Text] [Related]
35. Clozapine dosages and plasma drug concentrations.
Chang WH; Lin SK; Lane HY; Hu WH; Jann MW; Lin HN
J Formos Med Assoc; 1997 Aug; 96(8):599-605. PubMed ID: 9290269
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of clozapine in neuroleptic-resistant schizophrenia: clinical response and plasma concentrations.
Llorca PM; Lancon C; Disdier B; Farisse J; Sapin C; Auquier P
J Psychiatry Neurosci; 2002 Jan; 27(1):30-7. PubMed ID: 11836974
[TBL] [Abstract][Full Text] [Related]
37. Unanticipated plasma concentrations in two clozapine-treated patients.
Alfaro CL; McClure RK; Vertrees JE; Benavides R
Ann Pharmacother; 2001 Sep; 35(9):1028-31. PubMed ID: 11573850
[TBL] [Abstract][Full Text] [Related]
38. Association Between
Ishikawa S; Kobayashi M; Hashimoto N; Mikami H; Tanimura A; Narumi K; Furugen A; Kusumi I; Iseki K
J Pharmacol Exp Ther; 2020 Nov; 375(2):376-384. PubMed ID: 32862145
[TBL] [Abstract][Full Text] [Related]
39. Prediction of working memory performance in schizophrenia by plasma ratio of clozapine to N-desmethylclozapine.
Rajji TK; Mulsant BH; Davies S; Kalache SM; Tsoutsoulas C; Pollock BG; Remington G
Am J Psychiatry; 2015 Jun; 172(6):579-85. PubMed ID: 25859763
[TBL] [Abstract][Full Text] [Related]
40. Rapid capillary electrophoretic method for the determination of clozapine and desmethylclozapine in human plasma.
Raggi MA; Bugamelli F; Mandrioli R; Sabbioni C; Volterra V; Fanali S
J Chromatogr A; 2001 May; 916(1-2):289-96. PubMed ID: 11382303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
